• to lessen the potential risk of critical cardiovascular (heart and blood vessel) problems in Older people with type 2 diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk released a examine on scientific journal Mother nature a couple of novel glucose-sensitive insulin NNC2215 which can lower the risk of hypoglycemia in animal style… Read More